Cannabotech is developing oncology therapies that utilize cannabinoid and mushroom extracts to inhibit cancer cell proliferation and enhance the effectiveness of existing treatments. The company aims to improve patient outcomes by providing targeted therapies that reduce adverse side effects associated with conventional cancer treatments.
Funding
$8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Conventional cancer treatments often have adverse side effects, and existing therapies may not be effective for all patients. There is a need for targeted therapies that can inhibit cancer cell proliferation while minimizing harm to healthy cells.
Solution
Cannabotech is developing advanced medical solutions for cancer by combining cannabinoid and mushroom extracts. Their approach leverages the synergistic effects of multiple active botanical ingredients to create targeted therapies. These therapies aim to inhibit cancer cell proliferation and enhance the effectiveness of existing treatments, potentially leading to improved patient outcomes and reduced side effects. Cannabotech utilizes a modular approach to generate numerous medical solutions, creating versatile combinations and dynamic formulas to address the underlying issues of cancer treatment.
Target Audience
The primary target audience includes oncology patients seeking integrative therapies, healthcare professionals looking for innovative cancer treatments, and individuals interested in preventative health solutions.
Features
- Drug formulation method utilizing pure clinical, botanical qualities of cannabis, cannabinoids, and medicinal mushroom complexes
- Modular approach generating numerous medical solutions through versatile combinations and dynamic formulas
- Integrative medicine approach focusing on cannabis, cannabinoids, and medicinal mushroom complexes
- Smart packages, medical devices, personalized apps, and daily care products for real-time clinical progress detection
- M²CBD formula combining premium pharmaceutical-grade CBD with medicinal mushrooms for preventative health